One Death Linked To Calyxo Urological System

The US FDA has issued an early alert about the CVAC system from Calyxo, which urologists use in removing urinary stones.

(Shutterstock)

The US FDA has reported one death associated with the CVAC aspiration system and CVAC image processor from Calyxo, which are used to establish a channel during endoscopic urological procedures to treat and remove urinary stones.

The alert is part of the FDA’s ongoing pilot to improve its recall process by sending out advanced warnings on corrective actions the agency believes will...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Recalls

More from Policy & Regulation

FDA Rebukes Four Companies, Including One Overseas, For Procedural Failures

 

The US FDA’s device center sent warning letters to three domestic device manufacturers and one German firm for failing to adhere to protocol on several issues.

EU Finalizes Framework For Joint Clinical Assessments Of High-Risk Devices

 

Second submission window for joint scientific consultations on a procedure to help prepare for joint clinical assessments will open from 2 to 30 June 2025.

Get Ready For International Harmonization Before Approaching QMSR Deadline, Says Regulatory Expert

 

During MD&M East last week, regulatory consultant Darren Reeves reminded device manufacturers that the time to get ready to comply with the new Quality Management System Regulation is now.